For the best experience on the Abcam website please upgrade to a modern browser such as Google Chrome.
Synthetic phospho-peptide corresponding to residues surrounding Tyr1092 of human EGFR.
Produced using Abcam’s RabMAb® technology. RabMAb® technology is covered by the following U.S. Patents, No. 5,675,063 and/or 7,429,487.
An immunizing peptide is available for this antibody as ab190788.
Our Abpromise guarantee covers the use of ab40815 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
|IHC-FoFr||Use at an assay dependent concentration. PubMed: 18948956|
|WB||1/500 - 1/1000. Predicted molecular weight: 170 kDa.Can be blocked with EGFR (phospho Y1092) peptide (ab190788).|
|ICC/IF||1/250 - 1/500.|
|IHC-P||1/250 - 1/500.|
|IHC||Use at an assay dependent concentration. ab172730-Rabbit monoclonal IgG, is suitable for use as an isotype control with this antibody.|
ab40815 staining chondrocytes in tissue section (E13.5) of mouse limb, by immunohistochemistry (Formalin/PFA-fixed paraffin embedded sections). Tissue underwent fixation in paraformaldehyde, heat mediated antigen retrieval using 10mM Sodium Citrate buffer (pH 6.0) for 10 min at 95°C in a pressurized chamber and blocking in 5% serum for 1 hour at 25°C. Endogenous peroxidases were quenched with 3% H2o2 for 10 minutes. The primary antibody was diluted 1/250 in NGS buffer and incubated with sample for 8 hours at 4°C. A Biotin-conjugated goat polyclonal to rabbit IgG, diluted 1/500 was used as secondary. 1XTBS/0.1% Tween-20 (TBST) gave minimum background over 1XPBS as wash buffer.
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"